![]() |
Volumn 16, Issue 6, 2014, Pages 1366-1371
|
Evaluation of Acoustic Membrane Microparticle (AMMP) Technology for a Sensitive Ligand Binding Assay to Support Pharmacokinetic Determinations of a Biotherapeutic
|
Author keywords
acoustic membrane microparticle technology; biotherapeutics; emerging technology; ligand binding assays; pharmacokinetics
|
Indexed keywords
BIOLOGICAL MARKER;
LIGAND;
MONOCLONAL ANTIBODY;
ANTIBODY;
FLUORESCEIN;
PEGYLATED DOMAIN ANTIBODY;
UNCLASSIFIED DRUG;
BIOLOGICAL MODEL;
BLOOD;
DEVICES;
GENETIC PROCEDURES;
HUMAN;
IMMUNOASSAY;
LIMIT OF DETECTION;
MAGNETISM;
PROCEDURES;
REPRODUCIBILITY;
ACCURACY;
ACOUSTIC MEMBRANE MICROPARTICLE TECHNOLOGY;
ANTIGEN ANTIBODY COMPLEX;
ARTICLE;
BIOLOGICAL THERAPY;
BIOTECHNOLOGY;
CHEMOLUMINESCENCE;
COMPETITION ASSAY;
CROSS SITE TESTING;
DILUTIONAL LINEARITY;
DRUG SELECTIVITY;
LIMIT OF QUANTITATION;
LOWER LIMIT OF QUANTIFICATION;
MAXIMUM PLASMA CONCENTRATION;
OPTIMIZED ASSAY;
QUALITY CONTROL;
RECEPTOR BINDING ASSAY;
SANDWICH ASSAY;
SENSITIVITY ANALYSIS;
ANTIBODIES, MONOCLONAL;
BIOMARKERS;
BIOSENSING TECHNIQUES;
HUMANS;
IMMUNOASSAY;
LIGANDS;
LIMIT OF DETECTION;
MAGNETICS;
MODELS, BIOLOGICAL;
REPRODUCIBILITY OF RESULTS;
|
EID: 84938780044
PISSN: 00068101
EISSN: None
Source Type: Journal
DOI: 10.1208/s12248-014-9659-7 Document Type: Article |
Times cited : (5)
|
References (7)
|